The cytotoxicity of NK cells in patients with HCC is reduced. MDSCs inhibit NK cell cytotoxicity and IFN-γ release. MDSCs inhibit NK cells depending on cell contact. MDSCs inhibit NK cells for a long time. MDSCs use NKp30 receptors to inhibit NK cell function. Here, IFNG is linked to hepatocellular carcinoma.